This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Astellas Pharma Gmbh. Active years: 2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2011
Title: Kazuki Ono - Innovator in Sulfonamide Compounds
Introduction
Kazuki Ono is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific receptors associated with various medical conditions.
Latest Patents
Kazuki Ono holds a patent for a sulfonamide compound or salt thereof. This compound is designed to be used as an agent for treating diseases associated with the EP1 receptor, specifically targeting lower urinary tract symptoms. The invention highlights a sulfonamide compound characterized by an amide structure, where a carbon atom in the amide bonds to the nitrogen atom in sulfonamide through lower alkylene. This compound exhibits potent EP1 receptor antagonistic activity, making it a valuable asset in medical treatments.
Career Highlights
Kazuki Ono is currently associated with Astellas Pharma GmbH, a leading pharmaceutical company. His work focuses on innovative solutions that address pressing health issues through advanced chemical compounds.
Collaborations
Kazuki has collaborated with esteemed colleagues, including Issei Tsukamoto and Hideki Kubota, to further enhance the research and development of pharmaceutical innovations.
Conclusion
Kazuki Ono's contributions to the field of pharmaceuticals, particularly through his patented sulfonamide compound, demonstrate his commitment to advancing medical science. His work continues to pave the way for effective treatments for diseases associated with the EP1 receptor.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile